K-numberK250887
Device nameNeuromuscular Transmission Monitor TOF3D (2510091)
ApplicantMIPM Mammendorfer Institut für Physik und Medizin GmbH
Product codeKOI
Device classClass II
Decision dateOct 21, 2025
DecisionSubstantially Equivalent
Regulation868.2775
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The TOF3D is a neuromuscular transmission monitor used to objectively measure muscle contraction following electrical nerve stimulation during surgery or intensive care. It can also function as a peripheral nerve stimulator for subjective monitoring and is intended for use by anesthetists and nurses specializing in anesthesia care for patients aged 18 and older.

Technological characteristics

The subject device adds a mechanomyography (MMG) sensor option for direct force measurement, whereas the predicate uses acceleromyography (AMG) to calculate force. Both devices share identical maximum stimulation voltage (300 V), current range (0-60 mA), pulse width (monophasic 200-300 µs), stimulation patterns (TOF, PTC, TET, DBS, ST), accuracy (±5%), and contact characteristics (surface contact, intact skin, limited ≤24 hours).

Test standards cited

IEC 60601-1 (electrical safety), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-2-10 (nerve/muscle stimulator safety), IEC 60601-1-6 and IEC 62366-1 (usability), and ISO 10993-1 (biocompatibility). All testing was performed by independent accredited laboratories.

Substantial equivalence argument

The TOF3D with MMG sensor is substantially equivalent because it has identical intended use, user profile, and patient population as the predicate; employs substantially similar technological characteristics with only the measurement method differing (mechanomyography versus acceleromyography); and demonstrates equivalent safety and performance through comprehensive testing showing no new safety or effectiveness questions. The MMG sensor is reusable with identical biocompatibility and cleaning procedures as approved patient-contacting parts.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →